The presence of autoantibodies against myelin oligodendrocyte glycoprotein (MOG) is considered a hallmark of MOG antibody-associated disease (MOGAD), a recently defined demyelinating disease (8, 9) that presents with core clinical features such as optic neuritis, myelitis, and acute disseminated encephalomyelitis (8). This evidence concerns the gene MOG and optic neuritis.